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Abstract
The influenza viruses contain a segmented, single-stranded RNA genome of negative polarity. Each RNA segment is
encapsidated by the nucleoprotein and the polymerase complex into ribonucleoprotein particles (RNPs), which are
responsible for virus transcription and replication. Despite their importance, information about the structure of these RNPs
is scarce. We have determined the three-dimensional structure of a biologically active recombinant RNP by cryo-electron
microscopy. The structure shows a nonameric nucleoprotein ring (at 12 A˚ resolution) with two monomers connected to the
polymerase complex (at 18 A˚ resolution). Docking the atomic structures of the nucleoprotein and polymerase domains, as
well as mutational analyses, has allowed us to define the interactions between the functional elements of the RNP and to
propose the location of the viral RNA. Our results provide the first model for a functional negative-stranded RNA virus
ribonucleoprotein complex. The structure reported here will serve as a framework to generate a quasi-atomic model of the
molecular machine responsible for viral RNA synthesis and to test new models for virus RNA replication and transcription.
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Introduction
The influenza A viruses belong to the family Orthomyxoviridae and
are genetically and antigenically heterogeneous. They are respon-
sible for annual epidemics of respiratory disease and represent an
important public-health problem [1]. All viral subtypes can be
found in their natural reservoir, that comprises several wild avian
aquatic and terrestrial species. From this reservoir, influenza viruses
can occasionally infect mammalian species, including man, by
either gene reassortment with already established mammalian
viruses or by direct adaptation [2], and thus produce a pandemic.
Since 1997, transmissions of avian H5N1 influenza viruses to
humans have originated hundreds of highly pathogenic infections
and generated fears for a new pandemic of unprecedented impact
[2,3]. The recent transmission of swine H1N1 influenza viruses to
humans could represent the first time that a new pandemic can be
followed on line (http://www.who.int/csr/disease/swineflu/en/
index.html). The genome of the influenza A viruses comprise eight
single-stranded RNA molecules of negative polarity with partially
complementary ends that form a closed structure. The native
ribonucleoprotein (RNP) particles are formed by the association of
these single-stranded RNAs to multiple monomers of nucleoprotein
(NP) and a single copy of the polymerase, a heterotrimer composed
by the PB1, PB2 and PA subunits [4,5]. Such RNPs are
independent molecular machines responsible for transcription and
replication of each virus gene. When analysed structurally by
electron microscopy, virion RNPs appear as flexible, supercoiled
structures [6,7]. The helical organization of the RNPs is determined
by the structure of the NP, as complexes of NP and unrelated RNA
also adopt helical structures [8], and purified NP can form RNP-like
helical particles in the absence of RNA [9]. The polymerase
complex binds the vRNA promoter, that is formed by the partially
complementary 59- and 39-terminal sequences [10–12], and
determines the superhelical arrangement of natural virus RNPs
[13]. Although the RNPs are the essential elements for virus
replication and gene expression, their structural analysis has been
hampered by their heterogeneity and flexibility. However, in vivo
replication of recombinant model-RNPs indicated that helical-,
elliptic- or circular-shaped structures could be generated with RNA
templates of diminishing lengths [14]. The clone 23 model-RNP,
which represents the smallest efficient replicon, was circular in
shape and showed sufficient structural rigidity to be analysed by
electron microscopy and image processing after negative staining
[15]. Here we report the purification of recombinant clone 23 RNPs
to near homogeneity and their structural analysis by cryo-electron
microscopy (cryo-EM). It is important to stress that the RNPs
analysed were the final products of in vivo replication, as no RNP
accumulation was observed when NP or polymerase negative
mutants were used for in vivo reconstitution. The final structure
shows a resolution of 12 A˚ for the NP and 18 A˚ for the polymerase
complex and represents the first structure of a functional influenza
virus RNP and indeed of the RNP from any negative-stranded
RNA virus.
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Results
Generation and purification of a model recombinant RNP
Previously, we used recombinant RNPs purified by successive
glycerol gradient centrifugation steps to analyse their structure by
electron microscopy of negative-stained samples [15]. To improve
the purity and yield of the RNP preparations, we used a PB2
subunit containing a His-tag at the C-terminus, a modification that
did not alter the in vivo replication activity of the RNPs, as
described previously [16]. The purification protocol involved an
optimised Ni-NTA-agarose affinity step, a gel-filtration chroma-
tography and a final concentration on a Ni-NTA-agarose resin.
Such procedure allowed the routine preparation of essentially
homogeneous and biologically active RNPs with a concentration
appropriate for structural analysis (Fig. 1A–E). Most of the cellular
contaminants could be removed in the first Ni-NTA column, while
active RNPs were concentrated (Fig. 1A, B). The remaining
contaminants were eliminated by gel filtration (Fig. 1E), a step in
which the signals for the polymerase and NP co-migrated with the
in vitro transcriptional activity (Fig. 1C, D). The purified RNPs
(Fig. 1E, frame) were concentrated by binding to and elution from
Ni-NTA-agarose (data not shown) and used for cryo-EM.
Cryo-electron microscopy structure of a model
recombinant RNP
To generate an initial model for reconstruction, a purified RNP
sample was stained with uranyl-acetate and imaged at 20u tilt in a
FEI Tecnai G2 field emission gun microscope. A total of 2035
particle images were employed to generate a three-dimensional
reconstruction using the SPIDER algorithms [17]. To generate a
three-dimensional reconstruction of frozen-hydrated RNPs, sam-
ples of purified RNPs (Fig. 1E, frame) were fast-frozen on holey-
grids and imaged in the same microscope. A total of 9571
individual particle images were selected from the micrographs
after CTF correction and used for refinement (see Fig. S1 for a
gallery of single particle images). Two independent refinement
processes were carried out, with and without imposing 9-fold
symmetry. The three-dimensional reconstruction obtained by
Figure 1. Generation and purification of a model recombinant
RNP. (A) Recombinant RNPs containing a 248 nt long genomic RNA
were generated and amplified in vivo as indicated under Materials and
Methods. The RNPs containing a His-tagged PB2 protein (RNPs) were
purified by chromatography on Ni-NTA-agarose and the eluted
fractions were analysed by Western-blot using anti-PA and anti-NP
antibodies. As control, untagged RNPs were generated and purified in
parallel (CTRL). (B) The eluted fractions shown in (A) were assayed by in
vitro transcription. (C–E) The eluted RNPs were separated on a
Sephacryl S300 column and the fractions were analysed again by
Western-blot (C) and in vitro transcription as above (D), as well as by
silver-staining (E). The position of molecular weight markers (MW) is
indicated to the left. The stars indicate the position of the polymerase
subunits (POL) and the nucleoprotein (NP). The frame indicates the
fractions chosen for electron microscopy analyses.
doi:10.1371/journal.ppat.1000491.g001
Author Summary
The influenza viruses cause annual epidemics of respira-
tory disease and occasional pandemics that constitute a
major public-health issue. The recent spillover of avian
H5N1 and H1N1 swine influenza viruses to humans poses a
serious threat of a new pandemic. These viruses contain a
segmented RNA genome, which forms independent
ribonucleoprotein particles including the polymerase
complex and multiple copies of the nucleoprotein. Each
of these ribonucleoprotein particles are replicated and
express the encoding virus genes independently in the
virus-infected cells. To better understand how these
processes take place we have determined the three-
dimensional structure of a model ribonucleoprotein
particle that only contains 248 nucleotides of virus RNA
but is biologically active in vitro and in vivo. The structure
shows a circular appearance and includes 9 nucleoprotein
monomers, two of which are associated to the polymerase
complex. Docking of the available atomic structures of the
nucleoprotein and domains of the polymerase complex
has permitted us to propose a quasi-atomic model for this
ribonucleoprotein particle and some of the predictions of
the model have been confirmed experimentally by site-
directed mutagenesis and phenotype analysis in vitro and
in vivo.
Cryo-EM Structure for an Influenza Virus RNP
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imposing 9-fold symmetry lacked information about the polymer-
ase complex but could achieve better resolution for the NP ring.
On the contrary, refinement without imposing symmetry allowed
reconstruction of the complete RNP particle but the resolution
obtained was significantly lower (Fig. S2).
The final structure is shown in Fig. 2 and Video S1, and
represents a composite map formed by the 7 NP monomers not
contacting the polymerase, that are derived from the structure
refined with symmetry, while the polymerase complex, as well as
the 2 adjacent NP monomers are derived from the volume refined
without symmetry. Therefore, the resolutions for either section of
the model are different: 12 A˚ for the NP ring and 18 A˚ for the
polymerase complex (Fig. S3). Each NP monomer consists of two
domains, an upper head domain and a centred body, which
contains a small mass protruding at the bottom. When represented
at the calculated threshold no massive contacts among the NP
monomers were apparent, suggesting that the interaction sites are
flexible or random coil chains. The polymerase complex is in
contact with two of the NP monomers, which lack apparent
interaction with each other (Fig. 2).
Docking defined subunit domains in the structure of the
polymerase complex
The structure of the polymerase complex resembles that
previously obtained by negative-staining [16,18], but has higher
resolution. A comparison between both structures allowed the
localisation of specific subunit domains, as defined earlier by
binding of monoclonal antibodies or tagging (Fig. 3A) and suggest
that the main NP-polymerase interactions are mediated by the
PB1 and PB2 subunits. These interactions are quite different in
intensity, the former being stronger than the latter (Fig. 2, Fig. S2
and Video S1). Docking the recently reported atomic structure of
the PA(C)-PB1(N) dimer [19,20] was consistent with its predicted
localisation (Fig. 3B) [16] and would suggests that the PB1 and PA
subunits account for the upper, bulkier section of the complex
while PB2 would be localised at the bottom region.
Docking the NP atomic structure in the NP ring
We also carried out a docking of the atomic structure of the NP
in the cryo-EM reconstruction. The handedness of the cryo-EM
map was determined on the basis of the correlation coefficient of
the NP atomic structure docked into the symmetrised volume. The
fitting assays were carried out with both handednesses, using either
volumetric or laplacian criteria. The maximum correlation
coefficients were 0.854 and 0.341 for volumetric and laplacian
tests, respectively. These values were 2 to 30% better for the
selected as compared to the alternative handedness. In addition,
another important consideration indicates that the selected
handedness is correct. In the atomic structure of the influenza
NP (pdb accession number 2IQH) there are some portions of the
molecule that are not defined. The connections between the loop
402–428 (which is involved in NP-NP interaction; see below) and
the body of the molecule could not be determined (sequence
A428-S438). The distance between these two amino acids in the
selected fitting was around 25 A˚, compatible with a 10 amino
acids distance, whereas in the fitting performed in the structure
with the opposite handedness, these two amino acids were 41 A˚
apart.
The result of the docking is shown in Fig. 4A and confirms the
quality of the structural model obtained. A good fit is observed
between the two domains described in the atomic structure and
the volume of the NP monomer. However, additional masses are
observed at the top and at the bottom of each NP monomer. It
could be argued that such additional masses arise as a consequence
of using an initial negative-stain model that was derived by
conical-tilting. However, we used the same image data set to carry
out a control refinement, using as initial model a 9-mer-ring
structure generated with the atomic model of the NP filtered to a
resolution of 30 A˚, and the final model obtained was indistin-
guishable from that shown in Fig. 2 (data not shown).
Furthermore, the angular coverage of the images (Fig. S4) was
sufficient to exclude the missing cone as an explanation for this
extra volume. Thus, we feel that the additional masses detected in
the cryo-EM model of the NP monomers are bona fide.
We propose that the extra mass at the top of the NP monomer
corresponds to the protein sequences not solved in the crystal
structure [21] while that at the bottom may contain genomic
RNA. In fact, when decreasing threshold values were used to
represent the RNP volume, the additional mass at the bottom of
the NP was persistent, suggesting a high mass density (data not
Figure 2. Three-dimensional model of a recombinant virus mini-RNP. The final volume is a chimera containing the polymerase and two
adjacent NP monomers derived from a non-symmetrical volume and the rest of the NP ring derived from the symmetrical volume (see Fig. S2). (A)
Perspective view of the composite three-dimensional structure for the recombinant RNP. (B) Side views.
doi:10.1371/journal.ppat.1000491.g002
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shown). To test the potential RNA-dependence of the RNP
structure, these were purified by affinity chromatography on Ni-
NTA-agarose, extensively treated with T1 and pancreatic RNAses
and analysed by gel filtration. The results are shown in Fig. 5A and
clearly indicate that the interaction between the polymerase
complex and the NP ring is highly RNA-dependent, as both
substructures could be separated after RNAse treatment. On the
other hand, the size of the template RNA before and after
digestion with RNAse was analysed and a resistant band of around
18 nt was apparent (Fig. 5B). Since an average content of 24 nt
per NP monomer has been determined [14], this result would
suggest that most of the template RNA is uniformly distributed
along the RNP structure and protected by association to the NP.
Docking of the atomic structure of the NP monomers into the
cryo-EM structure also allowed us to predict their interaction
interfaces. It was earlier proposed that interaction of the loop 420
(positions 402–428) with a neighbouring NP monomer would
account for NP polymerisation [21], but this was suggested on the
basis of the formation of a crystallographic trimer and no
functional data was reported. The interaction among NP
monomers is conserved in the NP docking presented here, with
the only need to alter the angle between NP monomers from about
120u in the crystal to 40u in the RNP volume (Fig. 4A). This
interaction interface would be more realistic, as no NP trimeric
structure has been described in natural virus RNPs, and would
imply a small change in the arrangement of the connections
between the loop and the body of the NP (positions 428–438 and
396–402). These connections are in any case highly flexible and
were not resolved in the atomic structure of the trimer [21].
Although such a flexible connection is not detectable in the cryo-
EM map at the threshold shown in Fig. 4A (s= 2.5), it is clearly
visible when the volume is represented at s= 1.5 (Fig. 4B, blue
arrow).
Functional relevance of the predicted NP-NP contact
sites
It is not clear whether the contacts between the NP monomers
observed in the atomic structure of the trimer would be strictly
conserved in the functional RNP nonameric structure. Hence we
mutated several of the positions in the loop, affecting either
conserved or non-conserved amino acids (Fig. S5), and tested the
biological activity of the RNP. The replication of a viral RNP does
not lead to a naked progeny RNA but rather a progeny RNP
structure and it is generally accepted that encapsidation of the
newly synthesised RNA by the polymerase complex and NP
monomers is coupled to RNA replication. Hence, if the mutations
were to affect the NP-NP interaction, a deficiency in RNP
replication would be expected. Thus we reconstituted in vivo mini-
RNPs by transfection of plasmids encoding the polymerase
subunits (of which PB2 as a His-tagged protein), a clone 23
template RNA and either wt or mutant NP, and purified them by
Ni-NTA-agarose chromatography. The accumulation of progeny
RNPs was determined by Western-blot using anti-NP antibodies
and represents the in vivo replication phenotype. Mutants R416A
and F412A were strongly affected in replication, whereas mutants
S413T, F420A, K422A and S423A behaved as wt (Fig. 6A, B and
Fig. S5). These results confirm the relevance of the interaction
between R416 in the loop and E339 in the connecting NP [21]
and suggest that residue F420 in the loop does not play an
important role in the interaction. On the other hand, the
phenotype of mutant F412A indicates that it is important for
viral RNA replication. To further analyse the phenotype of the NP
mutants generated, the amount of purified mutant RNPs
recovered by replication in vivo was determined by measuring
their in vitro transcription activity. The results of a typical
experiment are presented in Fig. 7A and average of two
Figure 3. Docking the atomic structure of PA-PB1 complex into the RNP structure. (A) The insert shows the three-dimensional model for
the virus polymerase complex present in the RNP as reported by Area et al. [16]. The handedness of the structure has been reversed as compared to
the one published, as indicated by the docking of the atomic structure of the NP (see Supporting online material). The location of specific domains in
the PB1 (green), PB2 (red) and PA (violet) subunits are indicated. A front-view of the polymerase present in the RNP cryo-EM structure is presented,
with the locations of the polymerase domains as inferred from the negative-stained model. (B) The same front-view of the polymerase is presented
with the docking of the PA(C)-PB1(N) dimer. The N-terminal PB1 peptide is indicated with an arrow and highlighted in green.
doi:10.1371/journal.ppat.1000491.g003
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independent experiments is shown in Fig. 7B. These results are
consistent with the deficiency in the replication activity observed
for mutants R416A and F412A.
The replication-defective phenotype observed for these
mutants could be the consequence of a defect in their
homopolymerisation capacity. To analyse this possibility mutant
or wt NP were expressed by transfection in COS1 cells and total
extracts were analysed by gel-filtration after extensive RNAse
treatment. Under these conditions, wt NP formed large
complexes compatible with NP polymers. On the contrary,
mutant R416A, that was shown as negative in NP-NP
association [21], behaved as monomer (Fig. 8). The phenotype
of the other mutants correlated with their replicative activity in
vivo. Thus, mutant F420A behaved as wt while mutant F412A
showed an intermediate phenotype.
Discussion
In this report we have presented the three-dimensional structure
of an active influenza virus RNP, as determined by cryo-EM. In
fact, this represents the first structure of a biologically active RNP
from any negative-stranded RNA virus. Two technical develop-
ments have allowed this breakthrough: (i) the generation of
recombinant RNPs that are efficient replicons and have sufficient
structural rigidity [14] and (ii) the optimisation in the purification
protocols of RNPs amplified in vivo. As compared to full-length
virion RNPs, the structure reported here would represent a
minimal RNP in which the helical section has been deleted and
only the promoter region bound to the polymerase complex and
the terminal loop remains. The structure obtained for the
polymerase complex present in the RNP is compatible with those
reported earlier by negative-staining [16,18] and represents the
most accurate model for a complex polymerase of a negative-
stranded RNA virus thus far reported. The correlation with the
sites previously mapped [16] and the docking of the atomic
structure of specific domains permitted the rough localisation of
the polymerase subunits (Fig. 3). Unfortunately, the other
polymerase domains whose atomic structure is known [22–24]
are not large and conspicuous enough to allow unambiguous
docking in the cryo-EM structure.
The interaction among NP monomers was analysed by docking
of the atomic structure into the NP ring. The model obtained is
compatible with the interaction mode proposed earlier [21] and
further indicated that additional side-by-side interactions are now
possible due to the tighter packing of the monomers (see Fig. 4A,
black arrow). The relevance of the 420–428 loop in the NP-NP
Figure 4. Docking the atomic structure of NP monomers into the RNP model. (A) The atomic structure of NP [21] is represented within the
volume of the NP monomers derived from a reconstruction obtained imposing 9-fold symmetry. Upper and side views are presented. One of the
monomeric atomic structures is highlighted in blue to reveal the localisation of the connecting loop within the neighbouring monomer. The black
arrow points to the potential RNA connection among NP monomers. (B) Close-up view of three NP monomers represented at s=1.5. Upper and
perspective views are shown. The blue arrow points to the connection between the NP monomers at the top of the molecules. The presumptive
connection of the NP head and the loop inserted in the neighbouring monomer is indicated by a dotted line.
doi:10.1371/journal.ppat.1000491.g004
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interaction was verified functionally: The contacts of amino acid
R416 and F412 are essential for replication, while amino acid
K422 does not appear to be important, in spite of being conserved
among type A and B viruses (Fig. S5). Previous biochemical studies
had shown that residue R416 is involved in NP-NP interaction
[25] and that both F412 and R416 were important for RNA
binding [26]. In view of the results presented here it is possible that
the RNA-binding defect detected might be secondary to the
homopolymerisation failure. In addition, the residue at position
412 appears to be important for the template activity of the RNP,
since mutation F412A specially affected the in vitro transcription
of mutant RNPs (compare Figs. 5 and 6).
Contrary to the N-RNA complexes in the Mononegavirales
[27,28], that contain 9 nucleotides associated to each N
molecule, we have estimated an average of 24 nucleotides per
NP monomer in influenza RNPs [14]. The structure of the RNP
presented here is compatible with the RNA-binding site being
located at the groove between the head and body domains in
the NP, as previously suggested [21,29]. Indeed, a connecting
mass is apparent in the appropriate position (see Fig. 3A, black
arrow) that could represent the template RNA in addition to
protein contacts. However, most of the RNA sequence present
in the RNP is resistant to extensive RNAse treatment and the
main protected fragment is around 18 nt long (Fig. 5). This
Figure 5. Probing the RNP structure by RNAse treatment. Recombinant RNPs were generated and amplified in vivo as described in Fig. 1.
After purification by affinity chromatography on Ni-NTA-agarose, the RNPs were treated with a mixture of pancreatic RNAse (1.2 mg/ml) and T1
RNAse (30 u/ml) for 30 min at room temperature. As a control, the purified RNPs were similarly incubated in the absence of any RNAse. (A) The RNPs
were filtered on a Sephacryl S300 column as indicated in Fig. 1 and each fraction was analysed by Western-blot using antibodies specific for NP or PA.
The position of NP and PA is indicated to the right. (B) The RNA present in the RNAse-treated or mock-treated RNPs was extracted, terminally labelled
with c-32P-ATP and analysed on a 12% polyacrylamide-urea denaturing gel. Labelled oligonucleotides of 42 and 18 nt in length were run in parallel
(M). The mobility of molecular weight markers is indicated to the right.
doi:10.1371/journal.ppat.1000491.g005
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would suggest that the template RNA is distributed uniformly
along the RNP structure, i.e. variations of the average value of
24 nt per NP monomer are small. Furthermore, the size of the
protected fragment (18 nt) is similar to the average assignment
of RNA per NP, suggesting that the template RNA associates to
several regions of the NP and could contribute to the extra mass
observed at the bottom of each NP monomer. In addition, the
N-terminal region of NP, which has been implicated in binding
to RNA by biochemical assays [30] and is not represented in the
atomic structure of the protein [21,29], could also contribute to
this extra mass.
In summary, we have reported the first structure of a
biologically active influenza RNP. This three-dimensional struc-
ture reveals the NP-NP interaction domain and will serve as a
framework to generate a quasi-atomic model of the molecular
machine responsible for viral RNA synthesis.
Materials and Methods
Biological materials
The origin of plasmids pGPB1, pGPB2His, pGPA, pGNP(po-
lyA) and pT7DNSRT clone 23, containing sequences derived from
the A/Victoria/3/75 influenza virus strain, has been described
[14,16,31]. The vaccinia recombinant virus expressing T7 RNA
polymerase (vTF7-3) [32] was provided by B. Moss. The origin of
antibodies specific for PB1, PB2 and PA has been described
[14,33,34]. Antibodies specific for NP were generated by
immunisation of rabbits with purified His-NP. The NP mutants
were generated by site-directed mutagenesis on pGNP(polyA)
plasmid using the Stratagene Quickchange kit and specific
oligonucleotides (sequences available upon request) and their
genotype was verified by sequencing.
Amplification and purification of recombinant RNPs
Recombinant RNPs containing the DNS clone 23 genomic
RNA (248 nt) were generated and amplified in vivo by
transfection of plasmids pGPB1, pGPB2His, pGPA, pGNP(polyA)
and pT7DNSRT clone 23 into vaccinia vTF7-3-infected COS1
cells as described previously [16]. For RNP purification, the
clarified cell extracts were incubated overnight at 4uC with Ni-
NTA-agarose resin in a buffer containing 50 mM Tris-HCl-
100 mM KCl-5 mM MgCl2-0.5% Igepal-20 mM imidazol-1 u/
ml RNAsin-EDTA-free protease inhibitors cocktail, pH 8. The
resin was washed with 80 volumes of 50 mM Tris-HCl-100 mM
KCl-5 mM MgCl2-0.5% Igepal-20 mM imidazol, pH 8 and 20
volumes of the same buffer containing 50 mM imidazol. Finally,
the RNPs were eluted with 50 mM Tris-HCl-100 mM KCl-5 mM
MgCl2-0.5% Igepal-150 mM imidazol, pH 8. The eluted RNPs
were filtered on a Sephacryl S300 column equilibrated with
50 mM Tris-HCl-100 mM KCl-5 mM MgCl2-0.5% Igepal-
20 mM imidazol, pH 8 and the peak RNP fractions were further
bound to Ni-NTA-agarose in 50 mM Tris-HCl-100 mM KCl-
Figure 6. Phenotype of RNPs with NP mutations in the NP-NP interaction site. Recombinant RNPs were generated and amplified in vivo
using either wt of mutant NP as indicated. After purification of progeny RNPs by pull-down with Ni-NTA-agarose, their accumulation was determined
by Western-blot with anti-NP antibodies. (A) Results of a representative experiment, including the analysis of total cell extracts (Input) and the
purified RNPs (RNPs). (B) Average and range of two experiments.
doi:10.1371/journal.ppat.1000491.g006
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5 mM MgCl2-0.5% Igepal-20 mM imidazol-1 u/ml RNAsin-
EDTA-free protease inhibitors cocktail, pH 8, washed once with
50 mM Tris-HCl-100 mM KCl-5 mM MgCl2-0.5% Igepal-
20 mM imidazol, pH 8 and eluted with 50 mM Tris-HCl-
100 mM KCl-5 mM MgCl2-0.3% CHAPS-150 mM imidazol,
pH 8.
Biochemical techniques
Western-blotting was performed as described [14]. Protein
silver-staining was carried out as indicated before [35]. To
determine the transcription activity of purified RNPs, samples
were incubated in a buffer containing 50 mM Tris-HCl-2 mM
MgCl2-100 mM KCl-1 mM DTT-10 mg/ml actinomycin D-1 u/
ml RNAsin-1 mM ATP-1 mM CTP-1 mM UTP-10 mM a-P32-
GTP (20 mCi/mmol)-100 mM ApG for 60 min at 30uC. The RNA
synthesised was TCA precipitated, filtered through a nylon filter in
a dot-blot apparatus and quantified in a phosphorimager.
To test the in vivo RNP replication, cultures of COS1 cells were
infected with vaccinia vTF7-3 and transfected with plasmids
pGPB1, pGPB2His, pGPA, pGNP(polyA) (or mutants thereof) and
pT7DNSRT clone 23. Total cell extracts were used for
purification by affinity chromatography on Ni-NTA-agarose as
indicated above and the accumulation of progeny RNPs was
determined by Western-blot with anti-NP-specific antibodies and
by measuring their in vitro transcription activity.
To determine the NP aggregation state, cultures of COS1 cells
were infected with vaccinia vTF7-3 and transfected with plasmid
pGNP(polyA) (or mutants thereof). Total cell extracts were
prepared, treated with 50 mg/ml of RNAse A for 2 hours at
room temperature and analysed by filtration over a Sephacryl
S300 column calibrated with ferritin (440 kDa) and BSA (67 kDa).
Figure 7. Replication in vivo of RNPs containing wt or mutant NP. The assay for in vivo replication was performed as described in Materials
and Methods and the legend to Figure 6. The concentration of RNPs after purification by affinity chromatography was determined by in vitro
transcription. (A) Results of a representative experiment, including the analysis of total cell extracts (Input) and the purified RNPs (RNPs). (B) Average
and range of two experiments.
doi:10.1371/journal.ppat.1000491.g007
Figure 8. Homopolymerisation of wt or mutant NP. The
aggregation state of wt or mutant NPs was determined by gel filtration.
Cultures of COS1 cells were transfected with plasmids expressing either
wt of mutant NP, as indicated, and total cell extracts were treated with
RNAse and filtered on a Sephacryl S300 column. The eluted fractions
were analysed by Western-blot with anti-NP antibodies. The position of
ferritin (440 kDa) and bovine serum albumin (BSA; 67 kDa) is shown on
the top of the Figure.
doi:10.1371/journal.ppat.1000491.g008
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Electron microscopy and image processing
For electron microscopy of negatively stained samples 4 ml
aliquots of purified RNPs were applied to glow-discharged carbon
grids for 1 min and then stained for 1 min with 2% uranyl acetate.
Low-dose images were taken on a 200 kV FEI Tecnai G2 Field
emission gun electron cryomicroscope operated at a nominal
magnification of 50 k at 20u tilt. A total of 2035 individual RNP
images were extracted and processed to generate an initial model
using the SPIDER software [17].
For cryoelectron microscopy, 5 ml aliquots of purified RNPs
were applied to glow-discharged Quantifoil holey grids for 2 min,
blotted and frozen rapidly in liquid ethane at 2180uC. Images
were taken with the same conditions as in the negative stain
experiments but without tilting. The selected micrographs were
scanned on a Zeiss scanner (Photoscan TD, Z/I Imaging
Corporation) with a final pixel size corresponding to 2.8 A˚.
Contrast transfer function (CTF) of micrographs was estimated
using ctffind software [36] and corrected using Bsoft [37]. A total
of 9571 images were subjected to two independent refinements
with and without imposing 9-fold symmetry using SPIDER
software [17]. After reaching the convergence of these refine-
ments, the reconstructions yielded resolutions of 18 and 12 A˚ for
non-symmetrized and symmetrized structures, respectively (FSC
0.3 criterion). The final tilt range assigned in the refinement for the
whole set of individual images was checked (Fig. S5) and showed
an angular distribution where the effect of missing cone in the
reconstruction could be considered as negligible.
The absolute handedness of the volumes was determined using
the atomic structure of NP protein [21], and turned out to be the
opposite to that previously published [15,16]. Docking experi-
ments were carried out using SITUS software [38]. Finally, and to
verify the positions of the extra mass and the quality of the three-
dimensional reconstruction, an additional refinement was carried
out using as initial model the structure of the 9 NP-mer ring
resulting from the docking experiments, filtered at 35 A˚. This
refinement yielded a reconstruction similar to the final structure
presented here, showing that the additional masses detected in the
cryo-EM structure protruding from the NP monomers are bona
fide. Volume handling was carried out using XMIPP software [39]
and general visualization was performed using Chimera [40] and
Amira (http://amira.zib.de). The cryo-EM map has been
deposited in the Electron Microscopy Data Bank (accession code
EMD-1603) and the fitted atomic structure in the Protein Data
Dank (accession code 2wfs).
Supporting Information
Figure S1 Gallery of images. (A) Examples of images derived
from negative-stained samples used to generate the initial model
for reconstruction. (B) Images derived from frozen samples. The
corresponding projections of the final volume are presented to the
left to help in the identification.
Found at: doi:10.1371/journal.ppat.1000491.s001 (2.60 MB TIF)
Figure S2 Three-dimensional models generated by refinement
with and without imposed 9-fold symmetry. (A) Volumes obtained
after refinement without imposed symmetry. (B) Volumes obtained
after refinement with imposed 9-fold symmetry. Images at the top
show upper views while images at the bottom are lower views of
the structures.
Found at: doi:10.1371/journal.ppat.1000491.s002 (3.90 MB TIF)
Figure S3 Determination of resolution. The Fourier shell
correlation is presented as a function of the normalised frequency
for the reconstruction imposing 9-fold symmetry (blue) or without
imposing any symmetry (red). The inverse of the corresponding
resolution is indicated below each frequency value. The green line
denotes the FSC = 0.3 cut-off.
Found at: doi:10.1371/journal.ppat.1000491.s003 (0.51 MB TIF)
Figure S4 Assignment of tilt in three-dimensional reconstruc-
tion. The distribution of final tilt assigned to the complete set of
images after refinement is presented.
Found at: doi:10.1371/journal.ppat.1000491.s004 (0.63 MB TIF)
Figure S5 Mutations to analyse the NP-NP interaction site. (A)
The atomic structure of influenza NP is shown in an orientation
appropriate to see the protruding loop present around position 420
in the sequence. The relevant amino acids in the loop are
highlighted. (B) The mutations introduced in the loop are
indicated, including those involving non-conservative changes in
conserved positions (in red) and conservative changes in non-
conserved positions (in black). (C) Alignment of the relevant
sequence for influenza viruses of the A, B and C types indicating
the same mutations indicated in panel B.
Found at: doi:10.1371/journal.ppat.1000491.s005 (1.60 MB TIF)
Video S1 Movie of the RNP structure.
Found at: doi:10.1371/journal.ppat.1000491.s006 (8.08 MB
MOV)
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